Stevanato Group

Activities: Pharmaceutical

Trending Articles

  1. FDA Form 483 flags falsified records and live bird infestation at Dabur India OTC plant A FDA inspection report issued in January 2026 has revealed widespread CGMP failures at Dabur India's Dadra and Nagar Haveli facility, including manipulated microbiology data,...
  2. NSF announces fourth annual Pharma Biotech Conference 2026 Industry leaders to explore how pharma and biotech companies can build resilient quality systems beyond compliance
  3. From ozone protection to climate action: the global transition away from CFCs and HFAs background In the early 1990s, the world faced a stark environmental warning: the ozone layer, Earth’s natural shield against harmful ultraviolet radiation, was thinning at alarming...
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Why most organisations are failing AI and ISO 42001 audits — and how to fix it Eight in ten executives admit their company wouldn't pass an AI governance audit. With the EU AI Act arriving this August, ISOQAR's information security sector manager, Kirsty...
  5. Vetter named Best Managed Company for seventh year in a row The CDMO was the only company to be awarded Platinum status, having been recognised for its strategic focus, economic success and sustainability targets

Upcoming event

CPhI North America

2–4 June 2026 | Exhibition | Pennsylvania, US See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Distribution

How advanced injectables are redefining biopharma supply chain strategy

Demanding greater flexibility, regulatory rigour and end-to-end collaboration to ensure reliable global delivery, the rise of complex injectable therapies is pushing biopharmaceutical supply chains to evolve
Finance

Stevanato Group reports revenue of €280.0m for the second quarter of 2025

Company delivers 8% revenue growth, expanded margins and maintains fiscal year 2025 guidance
Sustainability

Manufacturing Chemist Stand Side with Stevanato Group

We discover what exhibitors at Pharmapack 2025 are showcasing LIVE!
Packaging

Nipro launches D2F Glass Vials powered by Stevanato Group's EZ-fill Technology

Nipro PharmaPackaging, a global leader in glass tubing, glass primary packaging, and medical devices, is proud to announce the launch of its innovative D2F (Direct-to-Fill) glass vials
Manufacturing

SCHOTT, Gerresheimer and Stevanato Group form the 'Alliance for RTU'

The scheme will promote the adoption of ready-to-use (RTU) vials and cartridges for CDMOs in the injectable scene
Manufacturing

Quantoom collaborates with Stevanato to elevate mRNA production

The two companies have entered into a collaboration to promote and democratise access to mRNA production technologies worldwide by launching Quantoom's Nfinity platform
Distribution

DWK enters into distribution agreement with drug containment specialist Stevanato

The collaboration will leverage DWK Life Sciences experience in supplying a global network of laboratories and biopharma customers to broaden the distribution of RTU products
Subscribe now